Category Archives: 2015

Hormonal Prostate Cancer Treatment May Double the Risk of Alzheimer’s Disease.

A recent study published in the Journal of Clinical Oncology comprising a large-scale analysis of medical records revealed that men undergoing androgen deprivation (hormonal) therapy (ADT) for prostate cancer treatment may be at almost twice the risk of eventually developing Alzheimer’s disease, and more »

Posted in 2015 | Leave a comment

A Must Read for Men Over 40: An Excellent Introduction to Prostate Cancer

Are you a man over 40 years of age and you are either concerned about or simply have some questions about prostate cancer?  Hopefully you may never need treatments of any kind but being informed is positive.  The November, 2014 more »

Posted in 2015 | Leave a comment

Prostate Cancer Patients Undergoing Active Surveillance Are Not Receiving the Proper Follow-Up.

A recent study from UCLA published in the December 1st issue of Cancer, included 3,600 men who had opted for active surveillance in place of aggressive treatment as a means of following the status of their prostate cancer.  The study found more »

Posted in 2015 | Leave a comment

The Effect of Stress on Prostate Cancer

The following is an edited version of a November 30th blog from Prostate Snatchers.  While I have experienced stressful episodes in my 20-year cancer experience, I find nothing works better than entrusting my body and its imperfections to its Creator more »

Posted in 2015 | Leave a comment

Cancer Patients Should Avoid Taking Antioxidant Supplements.

The following November 12th, 2015 article comes from the National Cancer Institute (NCI), the largest institute of the National Institutes of Health (NIH).  Antioxidants are often advertised to prevent the types of free radical damage that have been associated with more »

Posted in 2015 | Leave a comment

Ovarian and Breast Cancer Drug, Olaparib, is Effective in a Significant Number of Men with Advanced Prostate Cancer.

A major trial has concluded that a pioneering drug from AstraZeneca, olaparib, developed to treat women with inherited cancers, can also benefit men with certain types of advanced prostate cancer.  Olaparib inhibits the enzyme, poly (ADP ribose) polymerase (PARP), a more »

Posted in 2015 | Leave a comment

Prostate Cancer Diagnostic Testing Menu and MRI Review.

I recently came across the following menu of prostate cancer diagnostic tests offered by a specific facility.  The tests are mainly used to identify those cancers that may be aggressive requiring further biopsies or treatment.  The first group of tests more »

Posted in 2015 | Leave a comment

Men Who Speak Up

Bayer HealthCare is a strong proponent for men speaking up about prostate cancer.  They recently sponsored a symposium on the subject in which I participated.  If men were more vocal, prostate cancer funding hopefully might increase following the example of more »

Posted in 2015 | Leave a comment

Information on Prostate Supplements and PSA Testing

The Prostate Cancer Foundation (PCF) publishes a highly recommended e mail periodical entitled NewsPulse to which one can subscribe.  The October issue contained two articles which I will simply summarize and link. The first article concluded that popular prostate supplements more »

Posted in 2015 | Leave a comment

Should Men with a Rising PSA After Surgery Add Taxotere to Their Hormone Therapy?

A total of 413 relapsing prostate cancer patients whose PSA doubling time was less than nine (9) months and whose PSA was over 1.0 were evaluated.  Half of the men were treated with Lupron and the other half received Lupron more »

Posted in 2015 | Leave a comment